Dasatinib tablets are prescription anti-cancer medication used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) . It works as a tyrosine kinase inhibitor to block abnormal proteins in leukemia cells, specifically in patients who are newly diagnosed or resistant/intolerant to prior therapies, including imatinib.